Delivery Order SPE2DB22D9151-SPE2DB23FM8HF
Award Date 5/26/23
Potential Completion Date 6/20/23
Potential Value $19K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $15,474 delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/1.2 ml powder vials. The firm fixed price order is being fulfilled under the prime contractor's agreement with DLA and performance will take place in Park Ridge, Illinois, running from August 11, 2023 through September 1, 2023. No set aside designation or subcontracting details were provided. DLA manages the global supply chain for the military services and this order for the...
- The Defense Logistics Agency awarded a $18,568.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 mg/1.2 ml powder vials. The contract has a period of performance from September 1, 2023 through September 25, 2023, with place of performance in Park Ridge, Illinois. As the DLA supports military readiness by procuring and providing nearly 100% of the consumable items for the military services and several federal agencies, this delivery order is likely associated with...
- The Defense Logistics Agency awarded a $7,737 delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/1.2 ml powder vials. The firm fixed price order is being fulfilled under the prime contractor's agreement with DLA and performance will take place in Park Ridge, Illinois between August 30 and September 21, 2023. No set aside designation or subcontractors were indicated. DLA manages the global supply chain for the military and this order for the asthma drug Xolair is consistent...
- The Defense Logistics Agency awarded a $15,474 delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/1.2 ml powder vials. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DOD. Park Ridge, Illinois is the place of performance for delivery of the medication by August 30th, following a start date of August 9th. No set aside designation or subcontracting details were provided in the award...
- The Defense Logistics Agency awarded a $27,853.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/1.2 ml powder vials. The contract has a period of performance from July 25, 2023 through August 15, 2023, with all work to be performed in Park Ridge, Illinois. The DLA supports Department of Defense procurement and supply chain management, and this small contract will deliver an asthma medication to likely support military treatment facilities in the region....
- The Defense Logistics Agency awarded a $18,568.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 mg/1.2 ml powder vials. The contract has a period of performance from March 27, 2023 through April 17, 2023, with place of performance in Park Ridge, Illinois. As the DLA supports military readiness by procuring and providing nearly all consumable items for the military services, this delivery order is likely associated with the agency's medical supply chain and...
- The Defense Logistics Agency awarded a $15,474 delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/1.2 ml powder vials. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle to provide pharmaceutical products and services in support of DOD missions. Performance will take place in Park Ridge, Illinois over a three week period concluding July 27. No set aside designation or subcontracting details were provided. This order supports DLA's...
- The Defense Logistics Agency awarded a $74,275.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 mg/1.2 ml powder vials. The contract has a period of performance from June 23, 2023 through July 17, 2023, with all work to be conducted by DMS at its facility located in Park Ridge, Illinois. No subcontractors or set aside designations were identified. The DLA supports military readiness by procuring and providing logistics support for medical supplies and...
- The Defense Logistics Agency awarded a $27,853.20 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 mg/1.2 ml powder vials. The contract has a period of performance from May 1, 2023 through May 22, 2023, with place of performance in Park Ridge, Illinois. As the DLA supports the Department of Defense by procuring food, clothing, medicines, fuel and other supplies, this delivery order is likely associated with the agency's medical product procurement programs and will...
- The Defense Logistics Agency awarded a $15,474 delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/1.2 ml powder vials. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle to provide pharmaceutical products and services to DOD. Performance will take place in Park Ridge, Illinois over a three week period concluding in mid-July. No set aside designation or subcontractors were identified. This order supports DLA's mission to provide...
- SPE2DB22D9151Indefinite Delivery Contract
- SPE2DB22D9151-SPE2DB23FM8HFDelivery Order
The Defense Logistics Agency awarded a $18,568.80 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 mg/1.2 ml powder vials. The contract has a period of performance from May 26, 2023 through June 20, 2023, with place of performance in Park Ridge, Illinois. As the DLA supports military readiness through logistics solutions, this delivery order was likely placed to supply the asthma medication Xolair to military treatment facilities within the stated timeframe. No subcontractors or set aside designations were indicated.
Generated 12/30/23, 3:19 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.6k | 5/26/23 |